Answers are grounded in this paper and cite their sources.
A nitrofuran-containing medium, FTO agar, supported the growth of Micrococcus and prevented the growth of Staphylococcus. Its potential as a differential medium is considered worthy of clinical trial.
No takes yet. Share an insight, caveat, or question.
Curry et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: